- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Ed Cohen Describes the Major Medication-Related Quality Gaps in Transitions of Care Programs
Ed Cohen, PharmD, FAPhA, senior manager, product development, corporate innovations at Walgreens, explains that patient education and medication adherence are 2 major gaps in transitions of care.
Ed Cohen, PharmD, FAPhA, senior manager, product development, corporate innovations at Walgreens, explains that patient education and medication adherence are 2 major gaps in transitions of care. He says that the focus of Walgreens is to ensure that patients have an understanding of the medications they are prescribed, and how to take them. The company also confirms that patients are refilling their medications as prescribed.
Dr Ed Cohen adds that community and retail pharmacies traditionally provide bedside delivery of medications in transitions of care programs. Without this practice, some hospital goals cannot be met.
“Even our company, when we 1st entered into a collaboration with a health system to partner in transitions of care, our role was centered around bedside delivery of medication,” he says. “That particular hospital found that they were not able to attain their goals [of] reducing preventable readmissions around medication without the component of bedside delivery.”
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
